India · Delayed Price · Currency is INR Checkpoint Therapeutics Statistics
Total Valuation
NSE:EIEL has a market cap or net worth of INR 42.51 billion. The enterprise value is 43.09 billion.
| Market Cap | 42.51B |
| Enterprise Value | 43.09B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:EIEL has 175.53 million shares outstanding. The number of shares has increased by 16.87% in one year.
| Current Share Class | 175.53M |
| Shares Outstanding | 175.53M |
| Shares Change (YoY) | +16.87% |
| Shares Change (QoQ) | +17.04% |
| Owned by Insiders (%) | 71.71% |
| Owned by Institutions (%) | 1.95% |
| Float | 47.79M |
Valuation Ratios
The trailing PE ratio is 20.62.
| PE Ratio | 20.62 |
| Forward PE | n/a |
| PS Ratio | 3.86 |
| PB Ratio | 4.28 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 22.99 |
| EV / Sales | 3.91 |
| EV / EBITDA | 15.40 |
| EV / EBIT | 15.96 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | n/a |
| Interest Coverage | 9.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 18.20% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.71M |
| Profits Per Employee | 1.48M |
| Employee Count | 1,265 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:EIEL has paid 650.14 million in taxes.
| Income Tax | 650.14M |
| Effective Tax Rate | 25.53% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 245.56 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.58 |
| Average Volume (20 Days) | 6,910,210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:EIEL had revenue of INR 11.02 billion and earned 1.87 billion in profits. Earnings per share was 11.75.
| Revenue | 11.02B |
| Gross Profit | 3.74B |
| Operating Income | 2.70B |
| Pretax Income | 2.55B |
| Net Income | 1.87B |
| EBITDA | 2.80B |
| EBIT | 2.70B |
| Earnings Per Share (EPS) | 11.75 |
Balance Sheet
The company has 1.76 billion in cash and 2.34 billion in debt, giving a net cash position of -578.83 million or -3.30 per share.
| Cash & Cash Equivalents | 1.76B |
| Total Debt | 2.34B |
| Net Cash | -578.83M |
| Net Cash Per Share | -3.30 |
| Equity (Book Value) | 9.94B |
| Book Value Per Share | 56.66 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 33.90%, with operating and profit margins of 24.50% and 17.01%.
| Gross Margin | 33.90% |
| Operating Margin | 24.50% |
| Pretax Margin | 23.11% |
| Profit Margin | 17.01% |
| EBITDA Margin | 25.40% |
| EBIT Margin | 24.50% |
| FCF Margin | n/a |
Dividends & Yields
NSE:EIEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.87% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |